Joseph G. Marano

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering of common stock by iRhythm Technologies…

Davis Polk advised the representatives of the underwriters in connection with an approximately $963.5 million public offering of ordinary shares of Horizon Therapeutics Public Limited…

 Davis Polk advised the joint book-running managers in connection with concurrent SEC-registered offerings by II-VI Incorporated of 10,697,570 shares of its common stock for an…

Davis Polk advised Shockwave Medical, Inc. on its SEC-registered public offering of 1,955,000 shares of common stock for an aggregate price to the public of approximately $89.4 million,…

Davis Polk advised the joint book-running managers in connection with a $10 billion SEC-registered debt offering by Amazon.com, Inc., consisting of $1 billion of its 0.400% notes due…

Davis Polk advised the joint book-running managers and representatives of the initial purchasers in connection with a Rule 144A offering by 1Life Healthcare, Inc. of $275 million…

Davis Polk advised the underwriters in connection with an SEC-registered offering by Applied Materials, Inc. of $750 million aggregate principal amount of its 1.750% notes due 2030 and $750…

Davis Polk advised the joint book-running managers in connection with concurrent SEC-registered offerings by NeoGenomics, Inc. of 4,400,000 shares of its common stock and $175 million…

Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $750 million aggregate principal amount of 1.750% notes due 2030. Texas Instruments designs and…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Coherus BioSciences, Inc. of $200 million aggregate principal amount of its…